Print

Haemonetics Corporation (HAE) to Present at the Deutsche Bank (DB) 38th Annual dbAccess Health Care Conference  
5/24/2013 6:16:14 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BRAINTREE, Mass., May 23, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO & EVP-Business Development, will present at The Deutsche Bank 38th Annual dbAccess Health Care Conference in Boston, MA on May 29, 2013 at 1:30pm Eastern time.

(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )

The public may access Mr. Lindop's presentation live via webcast at: http://www.media-server.com/m/p/je7nwq7n

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

CONTACT:
Gerry Gould, VP-Investor Relations
Tel. (781) 356-9402
gerry.gould@haemonetics.com
Alt. (781) 356-9613

SOURCE Haemonetics Corporation

Help employers find you! Check out all the jobs and post your resume.

//-->